Cas 874199-34-5,(E)-tert-butyl 1-(4-bromothiophen-2-yl)-3-((dimethylamino)methylene)-4-oxocyclohexylcarbamate

874199-34-5

Post Buying Request

Basic information

Product Name: (E)-tert-butyl 1-(4-bromothiophen-2-yl)-3-((dimethylamino)methylene)-4-oxocyclohexylcarbamate
Synonyms: (E)-tert-butyl 1-(4-bromothiophen-2-yl)-3-((dimethylamino)methylene)-4-oxocyclohexylcarbamate
CAS NO:874199-34-5
Molecular Formula:
Molecular Weight: 429.378
EINECS: N/A
Product Categories: N/A
Mol File: 874199-34-5.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (E)-tert-butyl 1-(4-bromothiophen-2-yl)-3-((dimethylamino)methylene)-4-oxocyclohexylcarbamate(CAS DataBase Reference)
NIST Chemistry Reference: (E)-tert-butyl 1-(4-bromothiophen-2-yl)-3-((dimethylamino)methylene)-4-oxocyclohexylcarbamate(874199-34-5)
EPA Substance Registry System: (E)-tert-butyl 1-(4-bromothiophen-2-yl)-3-((dimethylamino)methylene)-4-oxocyclohexylcarbamate(874199-34-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 874199-34-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

874199-34-5 Suppliers

Recommended suppliersmore

874199-34-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 874199-34-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,4,1,9 and 9 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 874199-34:
(8*8)+(7*7)+(6*4)+(5*1)+(4*9)+(3*9)+(2*3)+(1*4)=215
215 % 10 = 5
So 874199-34-5 is a valid CAS Registry Number.

874199-34-5Upstream product

874199-34-5Downstream Products

874199-34-5Relevant articles and documents

OXIME DERIVATIVE HYDROXYETHYLAMINE ASPARTYL-PROTEASE INHIBITORS

-

Page/Page column 122; 124, (2010/02/15)

The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 874199-34-5